Stock Market Today: Nasdaq Climbs, Dow Slips After J&J Vaccine Stumble 

U.S. agencies recommended a pause in use of the Johnson & Johnson COVID vaccine amid rare instances of a blood clotting disorder, rattling the recovery trade Tuesday.

Johnson & Johnson/Janssen COVID-19 vaccine sits in a refrigerator.
(Image credit: Getty Images)

The "recovery trade" took a breather on Tuesday after a setback on the COVID vaccination front.

Both the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention urged a pause in injections of Johnson & Johnson's (JNJ, -1.3%) single-dose coronavirus vaccine so that the incidence of a blood clotting disorder in six Americans who have received the shot could be studied.

Subscribe to Kiplinger’s Personal Finance

Be a smarter, better informed investor.

Save up to 74%

Sign up for Kiplinger’s Free E-Newsletters

Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.

Profit and prosper with the best of expert advice - straight to your e-mail.

Sign up

Kyle Woodley was long NVDA as of this writing.

To continue reading this article
please register for free

This is different from signing in to your print subscription

Why am I seeing this? Find out more here

Kyle Woodley

Kyle Woodley is the Editor-in-Chief of WealthUp, a site dedicated to improving the personal finances and financial literacy of people of all ages. He also writes the weekly The Weekend Tea newsletter, which covers both news and analysis about spending, saving, investing, the economy and more.

Kyle was previously the Senior Investing Editor for, and the Managing Editor for before that. His work has appeared in several outlets, including Yahoo! Finance, MSN Money, Barchart, The Globe & Mail and the Nasdaq. He also has appeared as a guest on Fox Business Network and Money Radio, among other shows and podcasts, and he has been quoted in several outlets, including MarketWatch, Vice and Univision. He is a proud graduate of The Ohio State University, where he earned a BA in journalism. 

You can check out his thoughts on the markets (and more) at @KyleWoodley.